Schwartz, David T.
October 1970
Angiology;Oct1970, Vol. 21 Issue 9, p568
Academic Journal
Among 34 patients with gastrointestinal carcinoids, each of 9 patients with concomitant renal disease was hypertensive, and in 3 cases hypertension appeared with the tumor. Only one of 25 patients without renal disease was hypertensive. It was suggested that the potentiation of renal hypertension by carcinoid may be mediated by serotonin.


Related Articles

  • Hypertension in a cohort of African children with renal tumours. Hadley, G.P.; Mars, M. // Pediatric Surgery International;Mar2006, Vol. 22 Issue 3, p219 

    Hypertension is a frequent problem in children with renal tumour, yet there are few reports from centres in the third world. A retrospective study of blood pressure in a cohort of 46 patients with renal tumours seen over a 3-year period was carried out. Fifty percent of patients presenting with...

  • C. Hypertension and Systemic Disease.  // Kidney;May/Jun2005, Vol. 14 Issue 3, p121 

    Presents abstracts of several studies on hypertension and systemic disease. "Blood Pressure Drugs Differ in Efficacy in Black Patients," by L. M. Brewster, G. A. van Montfrans and J. Kleijnen, published in the 2004 issue of "Annals of Internal Medicine"; "Possible Serum Marker for Preeclampsia...

  • Blood pressure and chronic kidney disease progression in a multi-racial cohort: the Multi-Ethnic Study of Atherosclerosis. Larsson, A // Journal of Human Hypertension;Jul2013, Vol. 27 Issue 7, p403 

    The author presents insights on the association between hypertension and chronic kidney disease (CKD). He notes on the high cost of treating CKD, which is strongly associated with morbidity and mortality. He stresses the importance of developing effective treatments that reduce the progression...

  • Lead nephropathy. Bennett, William M. // Kidney International;Aug1985, Vol. 28 Issue 2, p212 

    Presents the case involving a 46-year-old man admitted to the hospital for evaluation of hypertension. Clinical manifestation; Diagnosis for lead nephropathy; Relationship of lead exposure to chronic renal failure.

  • Systemic hypertension versus intraglomerular hypertension in progression. Ritz, Eberhard; Orth, Stephan; Weinreich, Thomas; Wagner, J├╝rgen // Kidney International;Feb1994, Vol. 45 Issue 2, p438 

    Interprets indirect evidence available in the field about the relative roles of systemic versus glomerular hypertension in the progression of renal disease in humans. Implication of the fact that direct measurements of glomerular capillary pressure are not possible in humans; Effect of...

  • Prevalence and clinical correlates of white coat hypertension in chronic kidney disease. Roberto Minutolo; Silvio Borrelli; Raffaele Scigliano; Vincenzo Bellizzi; Paolo Chiodini; Bruno Cianciaruso; Felice Nappi; Pasquale Zamboli; Giuseppe Conte; Luca De Nicola // Nephrology Dialysis Transplantation;Aug2007, Vol. 22 Issue 8, p2217 

    Background. The role of white coat hypertension (WCH) in the poor control of blood pressure (BP) in chronic kidney disease (CKD) is ill defined. Methods. We measured systolic clinical (CBP) and ambulatory blood pressure (ABP) in 290 consecutive patients with non-dialysis CKD [glomerular...

  • Hypertension in chronic renal disease. Acosta, Jaime Herrera // Kidney International;Dec1982, Vol. 22 Issue 6, p702 

    Discusses the case of a 32-year-old man with chronic renal failure and severe hypertension. Symptoms experienced by the patient; Measurement of glomerular filtration rate; Hyperactivity of the autonomic nervous system; Role of circulating plasma renin activity in the hypertension.

  • Epidemic glomerulonephritis due to Streptococcus zooepidemicus in Nova Serrana, Brazil. Sesso, Ricardo; Wyton, Sergio; Pinto, L. // Kidney International Supplement;Aug2005, Issue 97, pS132 

    Epidemic glomerulonephritis due to Streptococcus zooepidemicus in Nova Serrana, Brazil. Background. In 1998, there was a large outbreak of acute glomerulonephritis in Nova Serrana, Brazil, caused by group C Streptococcus zooepidemicus. This article reviews the characteristics of the outbreak and...

  • Trial design: how must we move ahead? Seibold, J. R.; Tyndall, A.; Furst, D. E. // Rheumatology;Oct2008, Vol. 47, pv57 

    Scleroderma is clinically heterogeneous and a variety of plausible mechanisms of disease have been hypothesized. Recent years have witnessed a significant improvement in overall survival although all of the gains in management have been therapies for specific organ involvement, e.g. renal crisis...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics